Nolicin (Norfloxacin)

Norfloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes that control DNA supercoiling and replication. By preventing these enzymes from resealing DNA strands, the drug halts bacterial DNA synthesis, leading to bacterial cell death and resolution of the infection.

The dosage of Nolicin is determined by the prescribing clinician based on the infection type, severity, patient age, renal function and other clinical factors. The prescriber will select the appropriate strength, frequency and duration according to current treatment guidelines.

Safety data for norfloxacin in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and the decision must be made by a qualified health professional.

To request Nolicin, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Noricloxacin belongs to the fluoroquinolone class, similar to ciprofloxacin and levofloxacin. Compared with ciprofloxacin, norfloxacin has comparable activity against many urinary pathogens but may have a slightly lower potency against some respiratory organisms. Choice between agents depends on local resistance patterns, patient tolerance and specific infection site.

Nolicin tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or direct sunlight.

Nolicin is taken orally with a full glass of water. It may be taken with or without food, but if antacids or mineral supplements are used, they should be spaced at least two hours apart to avoid reduced absorption. Swallow the tablet whole; do not crush or chew unless instructed otherwise.

The most serious adverse events include tendon rupture or tendinitis, especially in older adults or those on corticosteroids; QT interval prolongation leading to cardiac arrhythmias; severe allergic reactions such as anaphylaxis; and Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if they experience sudden tendon pain, palpitations, severe rash or persistent diarrhea.

Nolicin should be avoided in individuals with a known hypersensitivity to norfloxacin, other fluoroquinolones, or any of the tablet excipients. It is generally not recommended for children, pregnant or breastfeeding women unless the benefit outweighs the risk, and it should be used with caution in patients with a history of tendon disorders or cardiac arrhythmias.